Rovena R Reagan MD

Obstetrics & Gynecology•San Diego, CA

Director and Principal Investigator - Women's Health Care Research Corp.

Join to View Full Profile

3750 Convoy StSte 311San Diego, CA 92111
Phone+1 858-505-8567
Fax+1 858-505-0104

Summary

Women's Health Care: Rovena Reagan MD - Gynecology & Research

Rovena Reagan, MD - Gynecology & Clinical Research Trials in San Diego, California. Leading the search for better women's health care!

Education & Training

University of Rochester Medical CenterResidency, Obstetrics and Gynecology, 1984 - 1988
University of Oklahoma College of MedicineClass of 1984

Certifications & Licensure

NY State Medical License 1985 - Present
CA State Medical License 1988 - 2025
American Board of Obstetrics and Gynecology Obstetrics & Gynecology

Awards, Honors, & Recognition

Fellow (FACOG) American Congress of Obstetricians and Gynecologists

Clinical Trials

Noninvasive Screening for Affected Pregnancies: Assay Development & Optimization in Affected Pregnancies Start of enrollment: 2009 Nov 01
Completed
Study of Contraceptive Efficacy & Safety of Phexxi™ (Previously Known as Amphora) Gel Compared to Conceptrol Vaginal Gel Start of enrollment: 2011 Apr 01
Completed
Phase 3
Specimen Collection from Pregnant Women At Increased Risk for Fetal Aneuploidy
RECRUITING
A Comparison of Estradiol Vaginal Cream to Estrace® Cream in 350 Postmenopausal Females With Atrophic Vaginitis Start of enrollment: 2014 Jun 01
Completed
Phase 3
Assess Safety and Efficacy of Vilaprisan in Patients With Uterine Fibroids Start of enrollment: 2015 Jun 01
Completed
Phase 2
E4 FREEDOM (Female Response Concerning Efficacy and Safety of Estetrol/Drospirenone as Oral Contraceptive in a Multicentric Study) - United States/Canada Study Start of enrollment: 2016 Aug 30
Completed
Phase 3
LIBERTY 1: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids Start of enrollment: 2017 Apr 26
Completed
Phase 3
Study Evaluating the Equivalence of GDC-229 and Metronidazole Vaginal Gel 0.75% in the Treatment of Bacterial Vaginosis Start of enrollment: 2017 Mar 10
Completed
Phase 3
Contraceptive Efficacy and Safety of NOMAC-E2 Combined Oral Contraceptive Start of enrollment: 2022 Feb 17
Terminated
Phase 3
Roles: Contact, Principal Investigator
Join now to see all

Research History

Principal InvestigatorPrincipal Investigator for Women's Health Care Research Corp. in San Diego, CA.2010 - Present

Professional Memberships

American College of Obstetricians and Gynecologists
Fellow

External Links

Websitehttp://whcresearch.com
Facebookhttps://www.facebook.com/womensclinicaltrials/